Estradiol Valerate

ๆˆŠ้…ธ้›ŒไบŒ้†‡

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEstradiol Valerate
Drug Alias Namevalerato de estradiol้›ŒไบŒ้†‡ๆˆŠ้…ธ้…ฏๆˆŠ้…ธ้›ŒไบŒ้†‡้…ฏestradioli valerasOestradiol Valerate +[13]ย 
ClassificationSmall molecules > Steroids
Mechanisms of ActionEstrogen receptors agonists
TargetsEstrogen receptors
Therapy Area/IndicationsOestrogen deficiency symptomsVasomotor symptomVulvar and vaginal atrophy +[7]ย 
Global Approved IndicationsOestrogen deficiency symptomsVasomotor symptomVulvar and vaginal atrophy +[6]ย 
Approved Indications in ChinaOestrogen deficiency symptoms
Original Approved Country/TerritoryUnited States
Original Approved Date1954/07/15
Country/TerritoryCanadaUnited StatesEgypt +[7]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEndo International Plc
China Registration ClassN/A

Develop Information

Active CompaniesPH Health LtdNovartis Pharmaceuticals Uk LtdBayer Plc +[6]ย 
Inactive CompaniesCairo University
Active IndicationsOestrogen deficiency symptomsVasomotor symptomVulvar and vaginal atrophy +[5]ย 
Inactive IndicationsEndocrine System DiseasesInfertility

Other Information

ATC CodeG03CA03
Related LinksWikipediaDrugBankKEGG